Showing results (181-190 of 188) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 188 results.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|December 15, 2017
A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303Hisashi Saji, Takahiko Ueno, Hiroshige Nakamura, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 2018
A phase II randomized trial of adjuvant chemotherapy with S-1 versus S-1 plus cisplatin for completely resected pathological stage II/IIIA non-small cell lung cancerTatsuro Okamoto, Tokujiro Yano, Mototsugu Shimokawa, et al.
Annals of Surgical Oncology|March 4, 2018
Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the LungTatsuro Okamoto, Kazuki Takada, Seijiro Sato, et al.
International Journal of Cancer|November 28, 2002
Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancerShinichi Toyooka, Riichiroh Maruyama, Kiyomi O Toyooka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2017
Alectinib for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status (Lung Oncology Group in Kyushu 1401)Eiji Iwama, Yasushi Goto, Haruyasu Murakami, et al.
Lung Cancer (Amsterdam, Netherlands)|March 22, 2025
CRES3T: A single-arm confirmatory trial of S-1 plus cisplatin with concurrent radical-dose radiotherapy followed by surgery for superior sulcus tumorsKazuya Takamochi, Kenji Suzuki, Morihito Okada, et al.
Cancer Science|November 13, 2020
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR)Kazuko Sakai, Masahiro Tsuboi, Hirotsugu Kenmotsu, et al.
Cancer Science|October 24, 2021
Predictive value of EGFR mutation in non-small-cell lung cancer patients treated with platinum doublet postoperative chemotherapyToshiaki Takahashi, Kazuko Sakai, Hirotsugu Kenmotsu, et al.
Pageof 19